Grants paid by Institute for Follicular Lymphoma Innovation
EIN 88-0639274 · Diamond Bar, CA · Form 990-PF, Part XV · NTEE T20
Institute for Follicular Lymphoma Innovation of Diamond Bar, CA (EIN 88-0639274) reported 24 grants paid totaling $15,527,562 to 16 recipients in tax years 2022–2024, on Form 990-PF, Part XV. It also reported $16,118,630 approved for future payment, which is listed separately and not included in the total. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$15,527,562
24 grants
Recipients
16
distinct organizations
Tax years
2022–2024
3 filings in the corpus
Approved for future payment
$16,118,630
17 commitments · not included in grants paid
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2022 | 5 | $1,453,863 | $2,071,179 |
| 2023 | 9 | $5,028,272 | $8,668,166 |
| 2024 | 10 | $9,045,427 | $5,379,285 |
Top recipients
The 16 recipients receiving the most from Institute for Follicular Lymphoma Innovation, by grants paid, out of 16 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Lysarc | U | Pierre Benite | 3 | $4,859,152 | 2024 |
| Lymphoma Research Foundation 95-4335088 | B | New York, NY | 1 | $3,282,650 | 2024 |
| The Leukemia & Lymphoma Society Inc | U | Rye Brook, NY | 3 | $1,511,957 | 2024 |
| Washington University 52-1538367 | B | St Louis, MO | 2 | $1,071,068 | 2024 |
| Mayo Clinic | U | Rochester, MN | 2 | $550,000 | 2023 |
| Stanford University 26-4580872 | C | Redwood City, CA | 1 | $550,000 | 2023 |
| Weill Cornell Medicine | U | New York, NY | 1 | $550,000 | 2023 |
| The University of Texas Md Anderson Cancer Center | U | Houston, TX | 1 | $550,000 | 2023 |
| University of Miami 59-0624458 | C | Coral Gables, FL | 2 | $550,000 | 2023 |
| UCLA 95-2250801 | D | Los Angeles, CA | 2 | $550,000 | 2024 |
| Beckman Research Institute - City of Hope | U | Duarte, CA | 1 | $467,783 | 2024 |
| Washington University 43-0653611 | C | St Louis, MO | 1 | $264,325 | 2022 |
| The Francis Crick Institute Limited | U | London | 1 | $249,969 | 2024 |
| Inserm | U | Paris, PARIS CEDEX 13 | 1 | $239,133 | 2024 |
| Cure (llsflfifli) | U | Rye Brook, NY | 1 | $223,667 | 2024 |
| Rafl Program (ifli & Lls Collaboration) | U | Rye Brook, NY | 1 | $57,858 | 2024 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 41 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Lymphoma Research Foundation New York, NY | B | $3,282,650 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2024 | Lysarc Pierre Benite | U | $2,336,450 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2024 | Lysarc Pierre Benite | U | $2,034,383 | approved, future | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2024 | The Leukemia & Lymphoma Society Inc Rye Brook, NY | U | $1,211,957 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2024 | Beckman Research Institute - City of Hope Duarte, CA | U | $1,151,166 | approved, future | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2024 | Washington University St Louis, MO | B | $700,961 | approved, future | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2024 | Washington University St Louis, MO | B | $700,960 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2024 | Beckman Research Institute - City of Hope Duarte, CA | U | $467,783 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2024 | Cure (llsflfifli) Rye Brook, NY | U | $447,333 | approved, future | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2024 | Inserm Paris, PARIS CEDEX 13 | U | $311,117 | approved, future | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2024 | Lymphoma Research Foundation New York, NY | B | $284,350 | approved, future | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2024 | UCLA Los Angeles, CA | D | $275,000 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2024 | The Leukemia & Lymphoma Society Inc Rye Brook, NY | U | $250,000 | approved, future | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2024 | The Francis Crick Institute Limited London | U | $249,969 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2024 | Inserm Paris, PARIS CEDEX 13 | U | $239,133 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2024 | Cure (llsflfifli) Rye Brook, NY | U | $223,667 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2024 | The Francis Crick Institute Limited London | U | $199,975 | approved, future | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2024 | Rafl Program (ifli & Lls Collaboration) Rye Brook, NY | U | $57,858 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202523219349108817 |
| 2023 | Lysarc Pierre Benite | U | $4,317,095 | approved, future | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202403209349107735 |
| 2023 | Lymphoma Research Foundation New York, NY | B | $3,050,000 | approved, future | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202403209349107735 |
| 2023 | Lysarc Pierre Benite | U | $2,008,164 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202403209349107735 |
| 2023 | Washington University St Louis, MO | B | $651,071 | approved, future | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202403209349107735 |
| 2023 | Weill Cornell Medicine New York, NY | U | $550,000 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202403209349107735 |
| 2023 | The University of Texas Md Anderson Cancer Center Houston, TX | U | $550,000 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202403209349107735 |
| 2023 | Stanford University Redwood City, CA | C | $550,000 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202403209349107735 |
| 2023 | The Leukemia & Lymphoma Society Inc Rye Brook, NY | U | $375,000 | approved, future | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202403209349107735 |
| 2023 | Washington University St Louis, MO | B | $370,108 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202403209349107735 |
| 2023 | UCLA Los Angeles, CA | D | $275,000 | approved, future | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202403209349107735 |
| 2023 | University of Miami Coral Gables, FL | C | $275,000 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202403209349107735 |
| 2023 | UCLA Los Angeles, CA | D | $275,000 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202403209349107735 |
| 2023 | Mayo Clinic Rochester, MN | U | $275,000 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202403209349107735 |
| 2023 | The Leukemia & Lymphoma Society Inc Rye Brook, NY | U | $175,000 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202403209349107735 |
| 2022 | Washington University St Louis, MO | C | $1,021,179 | approved, future | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202343199349110164 |
| 2022 | Lysarc Pierrebenite | U | $514,538 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202343199349110164 |
| 2022 | The Leukemia & Lymphoma Society Inc Rye Brook, NY | U | $500,000 | approved, future | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202343199349110164 |
| 2022 | University of Miami Coral Gables, FL | C | $275,000 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202343199349110164 |
| 2022 | Mayo Clinic Rochester, MN | U | $275,000 | approved, future | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202343199349110164 |
| 2022 | Mayo Clinic Rochester, MN | U | $275,000 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202343199349110164 |
| 2022 | University of Miami Coral Gables, FL | C | $275,000 | approved, future | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202343199349110164 |
| 2022 | Washington University St Louis, MO | C | $264,325 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202343199349110164 |
| 2022 | The Leukemia & Lymphoma Society Inc Rye Brook, NY | U | $125,000 | paid | FOR RESEARCH TOWARDS FINDING A CURE FOR FOLLICULAR LYMPHOMA | 202343199349110164 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990PF | 2024 | 2024-12-31 | not stated | 2024v5.2 | 202523219349108817 |
| 990PF | 2023 | 2023-12-31 | not stated | 2023v5.1 | 202403209349107735 |
| 990PF | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202343199349110164 |
Derived from IRS Form 990-PF e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/880639274.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.